Concise review: Using stem cells to prevent the progression of myopia - A concept

Stem Cells

Volumn 33, Issue 7, 2015, Pages 2104-2113

  Janowski, Miroslaw ^a,b   Bulte, Jeff W M ^a   Handa, James T ^c   Rini, David ^a   Walczak, Piotr ^a,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

Author keywords

Dopamine; Eye; Mesenchymal; Myopia; Nearsightedness; Sclera; Stem cells

Indexed keywords

AGE RELATED MACULAR DEGENERATION; ARTICLE; CHILDHOOD DISEASE; CONNECTIVE TISSUE; CORNEA DISEASE; DISEASE COURSE; DISEASE SEVERITY; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; ENVIRONMENTAL FACTOR; EYE DISEASE; EYE PROTECTION; GLAUCOMA; HIGH MYOPIA; HUMAN; MACULAR DEGENERATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOPIA; ONSET AGE; ORTHOKERATOLOGY LENS; PARKINSON DISEASE; RETINITIS PIGMENTOSA; SCLERA; STEM CELL TRANSPLANTATION; SUN EXPOSURE; SUNLIGHT; SURGERY; ANIMAL; METABOLISM; STEM CELL;

ANIMALS; HUMANS; MYOPIA; STEM CELLS;

EID: 84931564777     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1984     Document Type: Article

References (96)

1. Gilmartin B,. Myopia: Precedents for research in the twenty-first century. Clin Exp Ophthalmol 2004; 32: 305-324.
2. Wagle AM, Lim WY, Yap TP, et al., Utility values associated with vitreous floaters. Am J Ophthalmol 2011; 152: 60-65 e61.
3. Chuo JY, Lee TY, Hollands H, et al., Risk factors for posterior vitreous detachment: A case-control study. Am J Ophthalmol 2006; 142: 931-937.
4. Young FA, Leary GA, Baldwin WR, et al., The transmission of refractive errors within eskimo families. Am J Optom Arch Am Acad Optom 1969; 46: 676-685.
5. Yared AW, Belaynew WT, Destaye S, et al., Prevalence of refractive errors among school children in gondar town, northwest ethiopia. Middle East Afr J Ophthalmol 2012; 19: 372-376.
6. Moraes Ibrahim F, Moraes Ibrahim M, Pomepo de Camargo JR, et al., Visual impairment and myopia in Brazilian children: A population-based study. Optom Vis Sci. 2013; 90: 223-227.
7. Sun J, Zhou J, Zhao P, et al., High prevalence of myopia and high myopia in 5060 Chinese university students in Shanghai. Invest Ophthalmol Vis Sci 2012; 53: 7504-7509.
8. Morgan IG, Rose KA,. Myopia and international educational performance. Ophthalmic Physiol Opt 2013; 33: 329-338.
9. Rose KA, Morgan IG, Smith W, et al., Myopia, lifestyle, and schooling in students of Chinese ethnicity in Singapore and Sydney. Arch Ophthalmol 2008; 126: 527-530.
10. Tay MT, Au Eong KG, Ng CY, et al., Myopia and educational attainment in 421,116 young Singaporean males. Ann Acad Med Singapore 1992; 21: 785-791.
11. Vitale S, Sperduto RD, Ferris FL, 3rd. Increased prevalence of myopia in the United States between 1971-1972 and 1999-2004. Arch Ophthalmol 2009; 127: 1632-1639.
12. Czepita D, Lodygowska E, Czepita M,. Are children with myopia more intelligent? A literature review. Ann Acad Med Stetin 2008; 54: 13-16; discussion 16.
13. Lin HJ, Wan L, Tsai Y, et al., Muscarinic acetylcholine receptor 1 gene polymorphisms associated with high myopia. Mol Vis 2009; 15: 1774-1780.
14. Dobryakova YV, Gurskaya O, Markevich VA,. Participation of muscarinic receptors in memory consolidation in passive avoidance learning. Acta Neurobiol Exp 2014; 74: 211-217.
15. Kanazawa S,. Intelligence and childlessness. Social Sci Res 2014; 48: 157-170.
16. Kim MH, Zhao D, Kim W, et al., Heritability of myopia and ocular biometrics in Koreans: The Healthy Twin Study. Invest Ophthalmol Vis Sci 2013; 54: 3644-3649.
17. Ding X, Wang D, Huang Q, et al., Distribution and heritability of peripheral eye length in Chinese children and adolescents: The Guangzhou Twin Eye Study. Invest Ophthalmol Vis Sci 2013; 54: 1048-1053.
18. Stankovic-Babic G, Vujanovic M, Cekic S,. Identical twins with «mirror image» anisometropia and esotropia. Srp Arh Celok Lek 2011; 139: 661-665.
19. Tsai MY, Lin LL, Lee V, et al., Estimation of heritability in myopic twin studies. Jpn J Ophthalmol 2009; 53: 615-622.
20. Ip JM, Huynh SC, Robaei D, et al., Ethnic differences in the impact of parental myopia: Findings from a population-based study of 12-year-old Australian children. Invest Ophthalmol Vis Sci 2007; 48: 2520-2528.
21. Verhoeven VJ, Hysi PG, Wojciechowski R, et al., Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia. Nat Genet 2013; 45: 712.
22. Hawthorne FA, Young TL,. Genetic contributions to myopic refractive error: Insights from human studies and supporting evidence from animal models. Exp Eye Res 2013; 114: 141-149.
23. Tran-Viet KN, Powell C, Barathi VA, et al., Mutations in SCO2 are associated with autosomal-dominant high-grade myopia. Am J Hum Genet 2013; 92: 820-826.
24. Young TL, Ronan SM, Drahozal LA, et al., Evidence that a locus for familial high myopia maps to chromosome 18p. Am J Hum Genet 1998; 63: 109-119.
25. Young TL, Atwood LD, Ronan SM, et al., Further refinement of the MYP2 locus for autosomal dominant high myopia by linkage disequilibrium analysis. Ophthal Genet 2001; 22: 69-75.
26. Young FA,. The effect of restricted visual space on the refractive error of the young monkey eye. Invest Ophthalmol 1963; 2: 571-577.
27. Young FA,. The effect of atropine on the development of myopia in monkeys. Am J Optom Arch Am Acad Optom 1965; 42: 439-449.
28. Jeon S, Lee WK, Lee K, et al., Diminished ciliary muscle movement on accommodation in myopia. Exp Eye Res 2012; 105: 9-14.
29. Hung LF, Crawford ML, Smith EL,. Spectacle lenses alter eye growth and the refractive status of young monkeys. Nat Med 1995; 1: 761-765.
30. Smith EL, 3rd, Harwerth RS, Crawford ML, et al., Observations on the effects of form deprivation on the refractive status of the monkey. Invest Ophthalmol Vis Sci 1987; 28: 1236-1245.
31. Sherwin JC, Reacher MH, Keogh RH, et al., The association between time spent outdoors and myopia in children and adolescents: A systematic review and meta-analysis. Ophthalmology 2012; 119: 2141-2151.
32. Stone RA, Lin T, Laties AM, et al., Retinal dopamine and form-deprivation myopia. Proc Natl Acad Sci USA 1989; 86: 704-706.
33. Lin Z, Chen X, Ge J, et al., Effects of direct intravitreal dopamine injection on sclera and retina in form-deprived myopic rabbits. J Ocul Pharmacol Ther 2008; 24: 543-550.
34. Tkatchenko AV, Walsh PA, Tkatchenko TV, et al., Form deprivation modulates retinal neurogenesis in primate experimental myopia. Proc Natl Acad Sci USA 2006; 103: 4681-4686.
35. Guggenheim JA, Williams C, Northstone K, et al., Does vitamin D mediate the protective effects of time outdoors on myopia? Findings from a prospective birth cohort. Invest Ophthalmol Vis Sci 2014; 55: 8550-8558.
36. Yazar S, Hewitt AW, Black LJ, et al., Myopia is associated with lower vitamin D status in young adults. Invest Ophthalmol Vis Sci 2014; 55: 4552-4559.
37. Nelemans PJ, Rampen FH, Ruiter DJ, et al., An addition to the controversy on sunlight exposure and melanoma risk: A meta-analytical approach. J Clin Epidemiol 1995; 48: 1331-1342.
38. Elwood JM, Jopson J,. Melanoma and sun exposure: An overview of published studies. Int J Cancer 1997; 73: 198-203.
39. Gandini S, Sera F, Cattaruzza MS, et al., Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 2005; 41: 2040-2059.
40. Zanetti R, Rosso S, Martinez C, et al., Comparison of risk patterns in carcinoma and melanoma of the skin in men: A multi-centre case-case-control study. Br J Cancer 2006; 94: 743-751.
41. Schmitt J, Seidler A, Diepgen TL, et al., Occupational ultraviolet light exposure increases the risk for the development of cutaneous squamous cell carcinoma: A systematic review and meta-analysis. Br J Dermatol 2011; 164: 291-307.
42. de Vries E, Arnold M, Altsitsiadis E, et al., Potential impact of interventions resulting in reduced exposure to ultraviolet (UV) radiation (UVA and UVB) on skin cancer incidence in four European countries, 2010-2050. Br J Dermatol 2012; 167 (Suppl 2): 53-62.
43. Wang TJ, Chiang TH, Wang TH, et al., Changes of the ocular refraction among freshmen in National Taiwan University between 1988 and 2005. Eye (Lond) 2009; 23: 1168-1169.
44. Verhoeven VJ, Wong KT, Buitendijk GH, et al., Visual consequences of refractive errors in the general population. Ophthalmology 2015; 122: 101-109.
45. Tong L, Huang XL, Koh AL, et al., Atropine for the treatment of childhood myopia: Effect on myopia progression after cessation of atropine. Ophthalmology 2009; 116: 572-579.
46. Hiraoka T, Kakita T, Okamoto F, et al., Long-term effect of overnight orthokeratology on axial length elongation in childhood myopia: A 5-year follow-up study. Invest Ophthalmol Vis Sci 2012; 53: 3913-3919.
47. Kang P, Swarbrick H,. Peripheral refraction in myopic children wearing orthokeratology and gas-permeable lenses. Optom Vis Sci 2011; 88: 476-482.
48. Anstice NS, Phillips JR,. Effect of dual-focus soft contact lens wear on axial myopia progression in children. Ophthalmology 2011; 118: 1152-1161.
49. Thompson FB,. Scleral reinforcement for high myopia. Ophthal Surg 1985; 16: 90-94.
50. Balazs K, Bekesi L, Berta A, et al., Scleral reinforcement in progressive myopia and intraoperative ultrasound control of the cadaver fascia lata strip. Acta Chir Hung 1997; 36: 14-15.
51. Ward B, Tarutta EP, Mayer MJ,. The efficacy and safety of posterior pole buckles in the control of progressive high myopia. Eye (Lond) 2009; 23: 2169-2174.
52. Su J, Wall ST, Healy KE, et al., Scleral reinforcement through host tissue integration with biomimetic enzymatically degradable semi-interpenetrating polymer network. Tissue Eng Part A 2010; 16: 905-916.
53. Curtin BJ, Whitmore WG,. Long-term results of scleral reinforcement surgery. Am J Ophthalmol 1987; 103: 544-548.
54. Karabatsas CH, Waldock A, Potts MJ,. Cilioretinal artery occlusion following scleral reinforcement surgery. Acta Ophthalmol Scand 1997; 75: 316-318.
55. Jacob-LaBarre JT, Assouline M, Conway MD, et al., Effects of scleral reinforcement on the elongation of growing cat eyes. Arch Ophthalmol 1993; 111: 979-986.
56. Chen M, Dai J, Chu R, et al., The efficacy and safety of modified Snyder-Thompson posterior scleral reinforcement in extensive high myopia of Chinese children. Graefe's Arch Clin Exp Ophthalmol 2013; 251: 2633-2638.
57. Xue A, Bao F, Zheng L, et al., Posterior scleral reinforcement on progressive high myopic young patients. Optom Vis Sci 2014; 91: 412-418.
58. Qi Y, Duan AL, You QS, et al., Posterior scleral reinforcement and vitrectomy for myopic foveoschisis in extreme myopia. Retina 2014; 35: 351-357.
59. Zhu SQ, Wang QM, Xue AQ, et al., Posterior sclera reinforcement and phakic intraocular lens implantation for highly myopic amblyopia in children: A 3-year follow-up. Eye (Lond) 2014; 28: 1310-1314.
60. Gwiazda JE, Hyman L, Norton TT, et al., Accommodation and related risk factors associated with myopia progression and their interaction with treatment in COMET children. Invest Ophthalmol Vis Sci 2004; 45: 2143-2151.
61. Schwartz SD, Hubschman JP, Heilwell G, et al., Embryonic stem cell trials for macular degeneration: A preliminary report. Lancet 2012; 379: 713-720.
62. Sergienko NM, Shargorogska I,. The scleral rigidity of eyes with different refractions. Graefes Arch Clin Exp Ophthalmol 2012; 250: 1009-1012.
63. McBrien NA, Jobling AI, Gentle A,. Biomechanics of the sclera in myopia: Extracellular and cellular factors. Optom Vis Sci 2009; 86: E23-E30.
64. Ji X, Wang J, Zhang J, et al., The effect of posterior scleral reinforcement for high myopia macular splitting. J Int Med Res 2011; 39: 662-666.
65. Gilger BC, Abarca EM, Salmon JH, et al., Treatment of acute posterior uveitis in a porcine model by injection of triamcinolone acetonide into the suprachoroidal space using microneedles. Invest Ophthalmol Vis Sci 2013; 54: 2483-2492.
66. Einmahl S, Savoldelli M, D'Hermies F, et al., Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye. Invest Ophthalmol Vis Sci 2002; 43: 1533-1539.
67. Tyagi P, Barros M, Stansbury JW, et al., Light-activated, in situ forming gel for sustained suprachoroidal delivery of bevacizumab. Mol Pharm 2013; 10: 2858-2867.
68. Braun RD, Gradianu M, Vistisen KS, et al., Manganese-enhanced MRI of human choroidal melanoma xenografts. Invest Ophthalmol Vis Sci 2007; 48: 963-967.
69. Steinbach OC,. Industry Update: The latest developments in therapeutic delivery. Ther Deliv 2013; 4: 531-535.
70. Kim SH, Galban CJ, Lutz RJ, et al., Assessment of subconjunctival and intrascleral drug delivery to the posterior segment using dynamic contrast-enhanced magnetic resonance imaging. Invest Ophthalmol Vis Sci 2007; 48: 808-814.
71. Liu HS, Refojo MF, Albert DM,. Experimental combined systemic and local chemotherapy for intraocular malignancy. Arch Ophthalmol 1980; 98: 905-908.
72. Sharma T, Gopal L, Parikh S, et al., Parabulbar anesthesia for primary vitreoretinal surgery. Ophthalmology 1997; 104: 425-428.
73. Ripart J, Lefrant JY, Vivien B, et al., Ophthalmic regional anesthesia: Medial canthus episcleral (sub-tenon) anesthesia is more efficient than peribulbar anesthesia: A double-blind randomized study. Anesthesiology 2000; 92: 1278-1285.
74. Ankrum JA, Ong JF, Karp JM,. Mesenchymal stem cells: Immune evasive, not immune privileged. Nat Biotechnol 2014; 32: 252-260.
75. Tsai CL, Wu PC, Fini ME, et al., Identification of multipotent stem/progenitor cells in murine sclera. Invest Ophthalmol Vis Sci 2011; 52: 5481-5487.
76. Feldkaemper M, Schaeffel F,. An updated view on the role of dopamine in myopia. Exp Eye Res 2013; 114: 106-119.
77. Stone RA, Lin T, Iuvone PM, et al., Postnatal control of ocular growth: Dopaminergic mechanisms. Ciba Found Symp 1990; 155: 45-57; discussion 57-62.
78. Iuvone PM, Tigges M, Stone RA, et al., Effects of apomorphine, a dopamine receptor agonist, on ocular refraction and axial elongation in a primate model of myopia. Invest Ophthalmol Vis Sci 1991; 32: 1674-1677.
79. Rohrer B, Spira AW, Stell WK,. Apomorphine blocks form-deprivation myopia in chickens by a dopamine D2-receptor mechanism acting in retina or pigmented epithelium. Vis Neurosci 1993; 10: 447-453.
80. Gao Q, Liu Q, Ma P, et al., Effects of direct intravitreal dopamine injections on the development of lid-suture induced myopia in rabbits. Graefes Arch Clin Exp Ophthalmol 2006; 244: 1329-1335.
81. Mao J, Liu S, Qin W, et al., Levodopa inhibits the development of form-deprivation myopia in guinea pigs. Optom Vis Sci 2010; 87: 53-60.
82. McCarthy CS, Megaw P, Devadas M, et al., Dopaminergic agents affect the ability of brief periods of normal vision to prevent form-deprivation myopia. Exp Eye Res 2007; 84: 100-107.
83. Laties AM, Stone RA,. Some visual and neurochemical correlates of refractive development. Vis Neurosci 1991; 7: 125-128.
84. Guo SS, Sivak JG, Callender MG, et al., Retinal dopamine and lens-induced refractive errors in chicks. Curr Eye Res 1995; 14: 385-389.
85. Dong F, Zhi Z, Pan M, et al., Inhibition of experimental myopia by a dopamine agonist: Different effectiveness between form deprivation and hyperopic defocus in guinea pigs. Mol Vis 2011; 17: 2824-2834.
86. Schmid KL, Strasberg G, Rayner CL, et al., The effects and interactions of GABAergic and dopaminergic agents in the prevention of form deprivation myopia by brief periods of normal vision. Exp Eye Res 2013; 110: 88-95.
87. French AN, Ashby RS, Morgan IG, et al., Time outdoors and the prevention of myopia. Exp Eye Res 2013; 114: 58-68.
88. Caspi A, Vishne T, Reichenberg A, et al., Refractive errors and schizophrenia. Schizophr Res 2009; 107: 238-241.
89. Nowakowski A, Andrzejewska A, Janowski M, et al., Genetic engineering of stem cells for enhanced therapy. Acta Neurobiol Exp (Wars) 2013; 73: 1-18.
90. Shi D, Chen G, Lv L, et al., The effect of lentivirus-mediated TH and GDNF genetic engineering mesenchymal stem cells on Parkinson's disease rat model. Neurol Sci 2011; 32: 41-51.
91. Mack GS,. ReNeuron and StemCells get green light for neural stem cell trials. Nat Biotechnol 2011; 29: 95-97.
92. Katare R, Stroemer P, Hicks C, et al., Clinical-grade human neural stem cells promote reparative neovascularization in mouse models of hindlimb ischemia. Arterioscler Thromb Vasc Biol 2014; 34: 408-418.
93. Miller G,. Optogenetics. Shining new light on neural circuits. Science 2006; 314: 1674-1676.
94. Liang Y, Agren L, Lyczek A, et al., Neural progenitor cell survival in mouse brain can be improved by co-transplantation of helper cells expressing bFGF under doxycycline control. Exp Neurol. 2013; 247: 73-79.
95. Rohrer B, Stell WK,. Basic fibroblast growth factor (bFGF) and transforming growth factor beta (TGF-beta) act as stop and go signals to modulate postnatal ocular growth in the chick. Exp Eye Res 1994; 58: 553-561.
96. Mathis U, Schaeffel F,. Transforming growth factor-beta in the chicken fundal layers: An immunohistochemical study. Exp Eye Res 2010; 90: 780-790.